SCHEMBL18928951

SCHEMBL18928951

COc1cc(C)c(C)c(C(C)=O)c1C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.65
MAPK1 P28482 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
USP2 O75604 1/20 0.46
MAPT P10636 6/20 0.44
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
POLB P06746 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
HPGD P15428 1/20 0.44
GFER P55789 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
GAA P10253 2/20 0.44
FASN P49327 1/20 0.42
LMNA P02545 2/20 0.42
PKM P14618 1/20 0.42
HTT P42858 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
ALDH1A1 P00352 3/20 0.39
KCNA3 P22001 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3735175 0.80 CYP3A4 (0.47) CYP3A4MAPK1SMN1; SMN2USP2MAPT
SCHEMBL13601793 0.78 CYP3A4 (1.00) CYP3A4MAPK1SMN1; SMN2USP2MAPT
SCHEMBL801824 0.76 LMNA (0.62) CYP3A4KMT2AMEN1LMNAPKM
SCHEMBL29664473 0.74 CYP3A4 (0.58) CYP3A4MAPK1SMN1; SMN2USP2MAPT
SCHEMBL28132534 0.73 CYP3A4 (0.77) CYP3A4MAPK1SMN1; SMN2USP2KMT2A
SCHEMBL30892441 0.73 CYP3A4 (0.73) CYP3A4MAPTKMT2AMEN1POLB
SCHEMBL5588217 0.73 CYP3A4 (0.56) CYP3A4MAPTKMT2AMEN1POLB
SCHEMBL14511729 0.73 CYP3A4 (0.56) CYP3A4MAPTKMT2AMEN1POLB
SCHEMBL16226897 0.73 CYP3A4 (0.56) CYP3A4MAPK1SMN1; SMN2USP2MAPT
SCHEMBL31055010 0.73 CYP3A4 (0.77) CYP3A4MAPK1SMN1; SMN2USP2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017093938-A1 TETRAHYDROISOQUINOLINE DERIVATIVES VIIV HEALTHCARE UK LIMITED (GB) 2017-06-08 WO disclosed